Abstract
Saffron is an integral part of various traditional medicines containing several phytochemicals having disease preventing and health promoting properties. The antidepressant, cardio protective and chemopreventive properties of saffron can be attributed to its constinuent active phytochemicals and bioactive compounds like crocin, crocetin and safranal. Publicly available databases like NCBI-PubChem and ChEMBL have millions of bioactive compounds.This offers opportunity to mine the compound(s) of interest based on desired attributes in the therapeutic area of interest. The current review, attempts to identify potential of molecular basis of bioactive compounds of saffron.
Keywords: Active components, Crocus sativus L., saffron, toxicity.
Graphical Abstract
The Natural Products Journal
Title:Therapeutic Applications of Crocus sativus L. (Saffron): A Review
Volume: 6 Issue: 3
Author(s): Maryam Vahedi, Sumit Govil, Shailesh Kumar, Divya Shrivastava, Roghaye Karimi and Prakash S. Bisen
Affiliation:
Keywords: Active components, Crocus sativus L., saffron, toxicity.
Abstract: Saffron is an integral part of various traditional medicines containing several phytochemicals having disease preventing and health promoting properties. The antidepressant, cardio protective and chemopreventive properties of saffron can be attributed to its constinuent active phytochemicals and bioactive compounds like crocin, crocetin and safranal. Publicly available databases like NCBI-PubChem and ChEMBL have millions of bioactive compounds.This offers opportunity to mine the compound(s) of interest based on desired attributes in the therapeutic area of interest. The current review, attempts to identify potential of molecular basis of bioactive compounds of saffron.
Export Options
About this article
Cite this article as:
Vahedi Maryam, Govil Sumit, Kumar Shailesh, Shrivastava Divya, Karimi Roghaye and Bisen S. Prakash, Therapeutic Applications of Crocus sativus L. (Saffron): A Review, The Natural Products Journal 2016; 6 (3) . https://dx.doi.org/10.2174/2210315506666160502112533
DOI https://dx.doi.org/10.2174/2210315506666160502112533 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
Current Drug Targets Microgravity Alters Cancer Growth and Progression
Current Cancer Drug Targets Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Comparison of the Structure and Biological Activities of Wild-type and Mutant Liver-targeting Peptide Modified Recombinant Human Endostatin (rES-CSP) in Human Hepatocellular Carcinoma HepG2 Cells
Protein & Peptide Letters Selective Estrogen Receptor Modulators and Aromatase Inhibitors for Breast Cancer Chemoprevention
Current Drug Targets Expression and Characterisation of Recombinant Molecules in Transgenic Soybean
Current Pharmaceutical Design Molecular and Cellular Mechanisms of Hexavalent Chromium-Induced Lung Cancer: An Updated Perspective
Current Drug Metabolism In vivo 19F MR Studies of Fluorine Labeled Photosensitizers in a Murine Tumor Model
Current Drug Discovery Technologies Antitumor Activities of Interleukin-27 on Melanoma
Endocrine, Metabolic & Immune Disorders - Drug Targets Biodistribution and Pharmacokinetics of PEG-10kDa-Cholecystokinin-10 in Rats After Different Routes of Administration
Current Drug Delivery Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Current Cancer Drug Targets PET/CT Dose Planning for Volumetric Modulated arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients
Current Radiopharmaceuticals The Development of MetAP-2 Inhibitors in Cancer Treatment
Current Medicinal Chemistry Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events That Drive Metastasis
Anti-Cancer Agents in Medicinal Chemistry Targeted Therapy for Brain Tumours: Role of PARP Inhibitors
Current Cancer Drug Targets Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Current Pharmacogenomics Patent Selections
Recent Patents on DNA & Gene Sequences Ocular Inflammatory Diseases: Molecular Pathogenesis and Immunotherapy
Current Molecular Medicine New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
Current Pharmaceutical Design 1,3,5-Triazine Analogs: A Potent Anticancer Scaffold
Current Signal Transduction Therapy